Durante la presidencia de Joe Biden, la inscripción en Medicaid alcanzó un nivel récord y la tasa de personas sin seguro médico llegó a su nivel histórico más bajo. Pero se espera que el regreso de Donald Trump a la Casa Blanca, junto con un Senado y una Cámara de Representantes controlados por republicanos, cambie…
Una de las tareas del oncólogo es preparar a los pacientes con cáncer para tomar decisiones difíciles cuando se acerca el final. Sin embargo, no siempre se acuerdan de hacerlo. En el sistema de salud de la Universidad de Pennsylvania (Penn Medicine), un algoritmo de inteligencia artificial (IA) que predice las probabilidades de muerte de…
Program is designed to boost access to interventions such as long-acting injectable antipsychotics and medications for opioid use disorder and alcohol use disorder
Beleaguered for-profit hospital system will seek to sell off remaining operations outside of California
Health systems preparing for an M&A, or even those not immediately considering one, must prioritize a robust workforce data strategy. This approach is essential for navigating today’s increasingly frequent healthcare consolidations. The post Prioritize Provider Data for Seamless M&A Success appeared first on MedCity News.
AI is the next big thing, and most developers want to protect those programs and systems. The answer is intellectual property protection and specifically patent protection. The post AI, IP and Your Healthcare: And You Thought the Doctor’s Exam Was Intrusive! appeared first on MedCity News.
Under President Joe Biden, enrollment in Medicaid hit a record high and the uninsured rate reached a record low. Donald Trump’s return to the White House — along with a GOP-controlled Senate and House of Representatives — is expected to change that. Republicans in Washington say they plan to use funding cuts and regulatory changes…
Throughout her childhood, Julia Lo Cascio dreamed of becoming a pediatrician. So, when applying to medical school, she was thrilled to discover a new, small school founded specifically to train primary care doctors: NYU Grossman Long Island School of Medicine. Now in her final year at the Mineola, New York, school, Lo Cascio remains committed…
Gilead Sciences is acquiring LEO Pharma’s oral small molecule inhibitors of STAT6, a protein key to two validated inflammation pathways. Other STAT6 drug developers include Kymera Therapeutics and Sanofi-partnered Recludix Pharma, which is presenting this week during the J.P. Morgan Healthcare Conference. The post Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt…
HHS is proposing major changes to HIPAA for the first time in more than a decade, aiming to strengthen cybersecurity protocols for electronic health data. Healthcare cybersecurity leaders are mainly in favor of the proposal — though there are some concerns that smaller providers will struggle with the financial and operational burdens of compliance. The…